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[14C]-iodoantipyrine methods in normal con scious rats. I-CBF was reduced by 30-57% in the rats given MTX (100 mg or 200 mg/body) as compared to that in the saline injected control group, but no dose dependent effect was observed.
The mechanism of I-CBF reduction by MTX was discussed.
The administration of high-dose metho trexate (MTX) is now widely used in the treatment of osteogenic sarcoma and child hood brain tumors (1). However, this treat ment may lead to severe neurotoxicity such as acute encephalopathy (2) . To examine the mechanisms of MTX neurotoxicity, Phillips et al. (3) developed a model of acute high-dose MTX encephalopathy in the rat and found that MTX reduced cerebral glucose me tabolism in the absence of systemic organ toxicity. Silverstein and Johnston (4) re ported that MTX produced histopathologic changes in the brain and it disrupted the syntheses of some neurotransmitters, or af fected the metabolism in the rat. However, the effect of MTX on the cerebral circulation has not been studied. In the present study, we have examined the effect of MTX on local cerebral blood flow (I-CBF) in normal con scious rats.
CBF was measured by an autoradiographic technique (5) . Male Sprague-Dawley rats weighing from 300 to 460 g were anesthetized with halothane and N20, and polyethylene catheters were inserted into the femoral artery and vein for arterial blood sampling and for drug infusion, respectively. The rats were then immobilized by loosely fitted plaster casts. After recovering from anesthesia, low dose MTX (LD-MTX) rats (n=5) were infused intravenously with 100 mg of MTX in 6 ml of saline for 2 hr. Similarly, high dose MTX (HD MTX) rats (n=4) were infused with 200 mg of MTX, and control rats (n=4) were infused with 6 ml of saline. For the measurement of I-CBF, [14C]-iodoantipyrine was infused intravenously for 1 min, and the animals were then sacrificed by intravenous injection of 1 ml of saturated KCI solution. During the 1 min infusion period, 18-20 arterial samples were collected for measurement of 14C activity. The tissue activity was determined in 33 defined brain structures with quantitative autoradiography. Plasma MTX concentrations were measured 2 hr after the start of MTX infusion by a dihydrofolate reductase inhi bition assay (Methotrexate® kit, Lederle). Mean arterial blood pressure (MABP) was continuously monitored, and PaC02, Pa02, pH and hematocrit values were measured im mediately before I-CBF measurement. Sta tistically significant differences were deter mined using one-way analysis of variance Table 2 . Local CBF values (ml/100 g/min) in control and MTX continuous infusion rats followed by Tukey's procedure for multiple comparisons. Probability less than 0.05 was considered significant. Continuous intravenous infusion of MTX had no effect on physiological parameters compared with the controls (Table 1) . I CBF values in the LD-MTX and HD-MTX groups were reduced in all brain regions studied as compared with the control group ( Table 2) . A significant decrease was observed in 22 of 33 structures in the LD-MTX group and in 21 structures in the H D-MTX group. There was no significant difference of I-CBF between the LD-MTX group and the HD-MTX group. The smallest reduction in I-CBF (30%) was observed in the cerebellar nucleus and the most pronounced one (57%) in the auditory cortex and the medial geniculate.
In white matter structures, there was no significant decrease of I-CBF except for the internal capsule in the LD-MTX group. Plasma MTX concentration was 2.7 X 10-4 M in the LD MTX group and 5.0X10-4 M in the HD-MTX group.
(2.7x10_4 M) and HD-MTX group (5.0X10-4 M) are comparable to that reported in rats with acute high-dose MTX encephalopathy (3.2x10-4 M) (3). Thus, our study showed that the I-CBF reduced evidently in all brain regions as well as CMRg,,, by high-dose MTX neurotoxicity, even if a dose-dependent effect was not observed. Considering that the reduction of I-CBF paralleled that of CMRg111, the metabolic effect on I-CBF was strongly indicated.
